Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
David Fong
Observed name:
David H. Fong
Institution:
Amgen (United States)
Observed institutions:
Amgen (United States),
University of British Columbia
OpenAlex ID:
A5111769984
Discovery and in Vivo Evaluation of Dual PI3Kβ/δ Inhibitors
2012
·
Felix Gonzalez-Lopez de Turiso
, Youngsook Shin
, et al.
·
Journal of Medicinal Chemistry
·
53
Potent activity of soluble B7RP‐1‐Fc in therapy of murine tumors in syngeneic hosts
2002
·
Gulshan Ara
, Angelo Baher
, et al.
·
International Journal of Cancer
·
35
PDF
Expression of ORAI1, a Plasma Membrane Resident Subunit of the CRAC Channel, in Rodent and Non-rodent Species
2014
·
Roberto Guzman
, Eliane G. Valente
, et al.
·
Journal of Histochemistry & Cytochemistry
·
31
PDF
Lack of Correlation Between Growth of Tf-1 Cells and Tyrosine Phosphorylation Signals in Response to Il-3, Il-5 and Gm-csf
1997
·
Susan Ettinger
, David Fong
, et al.
·
Cytokine
·
11
Development of a QPatch-Automated Electrophysiology Assay for Identifying TMEM16A Small-Molecule Inhibitors
2020
·
Kathryn A. Henckels
, David Fong
, et al.
·
Assay and Drug Development Technologies
·
5
Effects of PTMs on mAb–Ligand Binding Assessed by SEC with LC-MS/MS and Correlation to Affinity and Potency Measurements
2026
·
Daniel W. Woodall
, David Fong
, et al.
·
Journal of the American Society for Mass Spectrometry
Show more works
View as search
Works count:
6
Citation count:
134
H-index:
5
I10-index:
4
Year
Topic
Type